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In this issue of Immunity, Hatton et al. (2006) identify
evolutionarily conserved noncoding sequences
(CNSs) upstream of the interferon-g gene, then show
by using a BAC transgene reporter that CNS-22 is
a key regulator of interferon-g expression.
CD4+ T cells adopt a diverse set of functional pheno-
types, each of which makes a unique contribution to
proper immunity. T helper 1 (Th1) and Th2 CD4+ T cells
were defined some time ago and shown to thwart infec-
tion by intracellular bacteria and viruses and by extra-
cellular parasites, respectively. More recently, regula-
tory T (Treg) cells, which moderate adaptive immune
responses, and Th17 CD4+ T cells, which are thought
to protect against extracellular bacteria, have been de-
fined. The choice between these lineages is made in re-
sponse to the environmental conditions present when
CD4+ T cells first encounter antigens. These choices
are entrained by lineage-specific transcription factors,
which for Th1, Th2, Treg, and Th17 cells are T-bet,
GATA3, FoxP3, and based on recent data, RORgt (Iva-
nov et al., 2006), respectively. How these ‘‘master regu-
lators’’ of CD4 lineage choice enforce commitment is in-
completely understood, in part because of our limited
knowledge of the genes and transcriptional regulatory
elements to which they bind. Th1, Th2, and Th17 cells
are defined by the signature cytokines they express,
and these ‘‘master regulators’’ appear to act in part by
binding to positive regulatory elements of the genes en-
coding these cytokines and perhaps also to negative
regulatory elements of the cytokines whose expression
is forbidden in that lineage.
In vertebrates, transcription is governed by the pro-
moter and additional regulatory elements located in in-
trons and at distances of 50 kb or more upstream or
downstream of the target gene. A clear example of this
paradigm is the evolutionarily conserved Th2 locus con-
taining the Il4, Il13, and Il5 genes. This locus, like the b-
globin locus, has been fertile ground for the discovery of
distal transcriptional regulatory elements (Lee et al.,
2006), and over the past decade, multiple groups that
have used a variety of computational and experimental
approaches have identified enhancers, silencers, and
locus-control regions that collaborate to ensure proper
expression of the Th2 cytokines.
By contrast, only recently have regulatory elements
other than the promoter and introns been identified for
Ifng, the gene encoding the signature Th1 cytokine in-
terferon-g. There is considerable evidence to indicate
that distal regulatory elements are required for proper
regulation of Ifng. The core Ifng promoter is T-bet
responsive in vitro (Cho et al., 2003) and directs Th1-
specific but low expression of transgenic reporters in
mice (Soutto et al., 2002). However, addition of 3.4 kb
of 50 flank to the core promoter leads to nonspecific
expression of the transgene (Zhu et al., 2001), andaddition of introns 1 and 3 or the use of an 8.6 kb genomic
human IFNG clone markedly augments expression but
abolishes Th1 specificity (Soutto et al., 2002). By
contrast, high-level, Th1-specific expression of human
IFNG is observed in mice transgenic for a bacterial
artificial chromosome (BAC) containing IFNG and ap-
proximately 95 kb of upstream and downstream flank
(Soutto et al., 2002), indicating that key regulatory ele-
ments not contained in the 8.6 kb transgene are present
in this BAC. Subsequently, using evolutionary conserva-
tion as a guide and Th1-specific DNase hypersensitivity
and transcriptionally favorable histone modifications as
landmarks, Lee et al. (2004) and Shnyreva et al. (2004)
identified two conserved noncoding sequences (CNSs)
that bind T-bet in vivo and enhance Ifng expression
in vitro; these were identified 5.5 kb upstream (CNS1)
and 17–19 kb downstream (CNS2) of murine Ifng, re-
spectively. Additional CNSs have been recently identi-
fied by cross-species comparison of sequences up-
stream or downstream of Ifng. Some of the newly
identified CNSs were shown to lie in regions marked by
transcriptionally permissive histone modifications, but
their function was not evaluated (Chang and Aune, 2005).
In this issue of Immunity, by comparing sequences up
to 60 kb upstream of Ifng in diverse vertebrate species,
Hatton et al. (2006) also identified CNS1 (which they re-
fer to as CNS-5) and the three additional upstream
CNSs first described by Chang and Aune (2005). Using
luciferase reporters in vitro, they demonstrated that
CNS-22 and CNS-34 are T-bet-dependent enhancers
when linked to the proximal Ifng promoter, with CNS-
22 being the stronger of the two (Figure 1A). T-bet
bound to both of these CNSs in vivo, as demonstrated
by chromatin immunoprecipitation, and also bound
weakly to CNS-55 and CNS-5, though they did not de-
tect enhancer activity with these latter two CNSs. The
failure to demonstrate enhancer activity for CNS-5 is
surprising because two other groups previously
showed that this CNS enhanced Ifng expression (Lee
et al., 2004; Shnyreva et al., 2004); this difference will
need to be resolved by further study. A number of fea-
tures led Hatton et al. to focus their attention more
closely on CNS-22: (1) T-bet-dependent enhancer activ-
ity was lost when a predicted T-bet binding site was mu-
tated; (2) In addition to T-bet, putative binding sites for
a number of transcription factors involved in T cell dif-
ferentiation and cytokine production were found in
CNS-22 and conserved across species; and (3) The his-
tones at CNS-22 had multiple marks of permissive chro-
matin not only in Th1 cells but also in naı¨ve and Th2
cells, suggesting that CNS-22 might have multiple con-
text-dependent functions. Then, taking advantage of
recent advances that permit the facile manipulation
of BACs, they introduced a Thy1.1 reporter into exon 1
of Ifng and placed this reporter into a BAC contain-
ing approximately 60 kb of upstream and approxi-
mately 100 kb of downstream flanking sequences. The
CNS-22 region of this BAC was then flanked with loxP
sites. Two lines of transgenic mice were generated with
this BAC, one with a single copy and another with more
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692Figure 1. Function of Upstream Conserved
Noncoding Sequences (CNSs) and Hypothet-
ical Architecture of the Murine Ifng Locus
(A) As shown by Hatton et al. (2006), T-bet
(yellow ovals) binds to each of the upstream
CNSs, and CNS-34 and CNS-22 enhance
Ifng-driven luciferase expression in the pres-
ence of T-bet (degree of enhancement indi-
cated by + marks). CNS-5 and CNS+17 are
shown as +? because they did not enhance
expression in this study but in two previous
studies enhanced Ifng expression in vitro
and bound T-bet in vivo (Lee et al., 2004;
Shnyreva et al., 2004). Previously defined
DNase hypersensitive sites are denoted by
downward arrows.
(B) Top, constitutive approximation of CNS-5
(dark green region on gray chromosome 10)
to the Ifng promoter (blue arrow) by intrachro-
mosomal looping and interchromosomal in-
teractions between the Ifng promoter and
the Th2 locus on (red region on black chro-
mosome 11) in naı¨ve and Th1 CD4+ T cells,
as shown by Spilianakis et al. (2005). Bottom,
hypothetical interactions based on Hatton
et al. Like CNS-5, CNS-22 (pink region) is
hypothesized to be juxtaposed to the Ifng
promoter and with the Th2 cytokine locus in
naı¨ve CD4+ T cells, whereas CNS-34 (light
green region) and CNS+17 (dark blue region)
are only recruited into the chromatin hub in
IFN-g producing Th1 cells.than 20 copies. In both lines, the Thy1.1 reporter was
expressed only in cells that also expressed endogenous
interferon-g after activation via the T cell receptor, iono-
mycin plus PMA, or IL-12 plus IL-18; such cells included
Th1 and CD8+ T cells and NK cells. Strikingly, when
CNS-22 was deleted from the single-copy transgene
by Cre recombinase, expression of the Thy1.1 reporter
was reduced >90% in each of these contexts. The
Thy1.1 reporter was not expressed by Th2 cells, regard-
less of whether CNS-22 was deleted. These results
show convincingly that CNS-22 is essential to ensure
proper, high-level expression of the Thy1.1 Ifng reporter
but not to silence reporter expression in Th2 cells.
These findings provide new insights regarding Ifng
regulation and open up avenues for future investigation.
A logical next step will be to define more fully the mech-
anism(s) by which CNS-22 facilitates proper expression
of Ifng. The most parsimonious interpretation of the
findings of Hatton et al. (2006) is that CNS-22 functions
as an enhancer in vivo, as it does in vitro. However, as
the authors note, this conclusion may be too simplistic,
in part because this was the only function assayed
in vitro, and the failure to identify additional functions
for CNS-22 in vivo (e.g., in silencing of Ifng expression
in Th2 cells) might have been masked by the loss of pos-
itive regulatory functions when this region was deleted
in its entirety. Given the presence of CNS-22 in open
chromatin in naı¨ve T cells, it is also possible that CNS-
22 facilitates expression of Ifng in part by helping to cre-
ate a locus architecture that is permissive to expression.
Such a function has been suggested for the two Ifng
CNSs previously identified. In naı¨ve CD4+ T cells, the
Ifng promoter is approximated by intrachromosomal
looping to CNS-5 (CNS1) and by interchromosomalinteractions to the Th2 cytokine locus on murine chro-
mosome 11 (Figure 1B). Differentiation of naı¨ve CD4+
T cells into Th1 cells markedly reduces the interaction
of the Ifng promoter with the Th2 cytokine locus and
results in the de novo approximation of CNS+17 (CNS-
2) to the Ifng promoter (Spilianakis et al., 2005). Might
CNS-22 participate in these context-dependent intra-
genic and intergenic interactions?
It will also be important to determine whether deletion
of CNS-22 from the endogenous Ifng locus abolishes
IFN-g expression as it did expression of the BAC-
encoded Thy1.1 reporter. There are reasons to suspect
that CNS-22 may be important but not absolutely es-
sential in its native context. Although the Thy1.1 re-
porter was expressed only in cells that also expressed
interferon-g, only 13%–50% of interferon-g-expressing
cells also expressed Thy1.1. Moreover, expression from
the >20-copy and single-copy BAC transgenes was
similar. Together, these two findings indicate that this
BAC lacks a locus-control region, which, if present,
would have resulted in copy-number-dependent ex-
pression of the transgene by insulating it from local en-
vironment in which the transgene integrated (Lee et al.,
2006). Thus, assuming that there is an Ifng locus-control
region, it does not appear to lie within about 60 kb
upstream or about 100 kb downstream of the murine
Ifng gene. Future studies should also address the
possibility that the CNSs now identified have functions
not yet addressed and determine if any non-CNS se-
quences also contribute to proper Ifng expression. Al-
though evolutionarily conserved regions are more likely
to contain regulatory elements, a considerable fraction
of regulatory elements that lack the requisite degree
of sequence conservation to be considered CNSs have
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693been identified by non-targeted approaches, such as
comprehensive DNase-hypersensitivity-site or chroma-
tin immunoprecipitation assays. Thus, an unbiased
search of the Ifng locus may identify important regula-
tory elements in addition to those that have now been
identified.
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Peptides Made to Order
How loading of major histocompatibility complex
(MHC) class I-specific peptides by conserved degra-
dation machinery is performed economically has
now been resolved by Kanaseki et al. (2006) in this
issue of Immunity: The individual MHC molecule
serves as a template for its own ligand.
MHC class I molecules, the peptide receptors that sam-
ple cellular protein-degradation products for display on
the surface, are of exceptional specificity. Their ligands
are peptides of defined lengths—9 amino acids in most
cases—and have certain sequence characteristics that
are summarized as motifs (Falk et al., 1991). MHC genes
exhibit a remarkable polymorphism; for the human MHC
class I genes (human leukocyte antigen [HLA]-A, B, and
C), for example, around 1500 different alleles are known
to date, and each allelic product has its own distinct
peptide-receptor specificity. This polymorphism pro-
vides powerful protection within a host population
against attempts by intracellular pathogens to escape
immune recognition.
In sharp contrast to the polymorphic MHC genes, the
components of antigen processing are very conserved
(Pamer and Cresswell, 1998). Thus, we run into a conun-
drum. How can the protein-degradation machinery of
the cell provide peptides with specificity for so many
different MHC molecules? Does the degradation ma-
chinery generate all possible permutations of size and
specificity from each protein molecule? Early experi-
ments indicate that such preformed peptides cannot
be found in a cell unless the fitting MHC molecule
is coexpressed (Falk et al., 1990). This led to the hypoth-
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templates for shaping their own ligands. An alternative
explanation, however, would be that all peptide permu-
tations are produced and only the ones that are pro-
tected from further degradation by binding to an MHC
molecule are degraded further, and so rapidly that they
remain undetectable experimentally.
We now have a better understanding of how the con-
served protein-degradation machinery can serve all
existing MHC I molecules. It is a process consisting of
several steps. The last step is, however, the most so-
phisticated one, as Kanaseki et al. (2006) demonstrate.
Let us now follow the main protein-degradation path-
way for MHC I loading step-by-step (see Figure 1). First,
we have the cleavage of ubiquitinated protein by the
proteasome. The proteasome cleaves proteins into
peptides of roughly 5–20 amino acids (aa), mostly with
hydrophobic or basic C termini, which, as far as we
know, are preferred by mammalian MHC binding
pockets (Stevanovic, 2005). Thus, the C termini of the
peptides leaving the proteasome already constitute
the C termini of the final MHC ligands. Peptides are
now attacked by cytosolic aminopeptidases such as
bleomycin hydrolase or puromycin-sensitive amino
peptidase (Stoltze et al., 2000). The latter have also re-
cently been shown to have some specificity for serving
MHC I molecules; they tend to spare those N-terminal
amino acids that are favored by the following step,
which is the transport of peptides by the transporter as-
sociated with antigen processing (TAP) into the endo-
plasmatic reticulum (ER) lumen (M. Schatz and H.
Schild, personal communication). TAP has a specificity
for a certain peptide length, for hydrophobic and, for
humans, also for basic C termini. Once they arrive in
the ER lumen, the peptides are attacked by luminal ami-
nopeptidases, ERAAP I and ERAAP II, and eventually
destroyed completely if not protected by binding to an
MHC molecule (Serwold et al., 2002; Saric et al., 2002;
